Canadian drugmaker has underlined its determination to buy the maker of Botox by raising the cash component of its offer to $72 a share
Source: Companies
Author
Harry Joiner
“… a dominant recruiter in the client-side multichannel ecommerce space …” — SearchEngineWatch.com